Skip to main content
. 2022 Jun 28;12:880459. doi: 10.3389/fonc.2022.880459

Figure 11.

Figure 11

Downregulation of RPARP-AS1 inhibited osteosarcoma cell growth migration, and invasion. (A) Survival analysis of osteosarcoma patients with high and low RPARP-AS1 expression. (B) RPARP-AS1 expression in osteosarcoma cell lines and osteoblast cell line. (C) Transfection efficiency of si-RPARA-AS1 in MNNG/HOS and U2OS cells. (D, E) CCK-8 (D) and colony formation (E) assays were utilized to detect the proliferative capacity of MNNG/HOS and U2OS cells after RPARP-AS1 downregulation. (F, G) Transwell assays were applied to determine the migration (F) and invasion (G) capacity of MNNG/HOS and U2OS cells after RPARP-AS1 downregulation (magnification, 100×). **p < 0.01.